Professor Bengt Winblad, MD, PhD has been involved in the field of dementia research for many years. After pre-clinical medical studies in Vienna, Austria, he became MD 1971 and took his PhD in 1975 at Umeå University, Sweden, where he became a Docent in 1977 and Professor of Geriatric Medicine and Chief Physician in 1982. Since 1987, he is working in Stockholm, Sweden as Professor of Geriatric Medicine at the Karolinska Institutet and is Chief Physician at Karolinska University in Huddinge. Professor Winblad is Director of KI-Alzheimer Disease Research Center (KI-ADRC) in Huddinge, as well as the Swedish Brain Power research network.
He is co-chairing the European Alzheimer Disease Consortium (EADC) and is the PI of the European Union Joint Program on Neurodegenerative Disorders (JPND) project BIOMARKAPD. He chaired the Medical Scientific Advisory Panel of the Alzheimer Disease International (ADI) 2007-2013.
Bengt Winblad has been a guest professor at the Department of Psychiatry in Frankfurt and appointed honorary professor at Beijing University, Wuhan University and Shanghai University in China.
Bengt Winblad’s research interests are experimental and clinical Alzheimer research with a translational approach and focus on early diagnosis and treatment. He has been presented with a number of awards for his contribution to this research area, which have included the Swedish Society of Medicine Alzheimer Award, the Royal Swedish Academy of Medical Sciences Award, the Aloïs Alzheimer Award, the Swedish Society of Medicine Award and the IPA Recognition Award for Service to the Field of Psychogeriatrics. He has taken the initiative regarding pharmaceutical treatment of patients with severe Alzheimer’s disease. Professor Winblad has been a tutor for more than 150 PhD students and has published >1000 original publications in the field of gerontology/geriatrics/dementia research.
Bengt Winblad, together with Khalid Iqbal and Henry Wisniewski, is the founder of the ICAD conferences (currently renamed AAIC).
Bengt Winblad was in 2009 ranked the world’s most profilic researcher in the Alzheimer field (J Alzheimer’s Disease 2009).